Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, China
Location status: Recruiting
Recruiting
NCT Number: NCT04709432
ECMO Treatment of Children in China in the Past 10 Years
It is a cross-sectional study to summarize the extracorporeal membrane oxygenation （ECMO）treatment in children in China.
Recruiting
Interested in participating?
Request InfoKey information
Conditions
Age range
1 day–18 year
Sex eligibility
All sexes
Study type
Observational
Primary location
About this study
ECMO treatment in children is still in its infancy in China, and it has made considerable progress in recent years. In order to further understand the development of ECMO treatment in critically ill children, the investigator conduct this cross-sectional research through questionnaires. The investigator collect general information of the hospital and ECMO equipment, etiology, compilation, and mode of ECMO.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- age of 1d to 18 years old;
- children supported by ECMO in mainland China in the past 10 years
Exclusion criteria
- none
Treatment and study plan
ECMO
ProcedureECMO is a form of Extracorporeal Life Support (ECLS) to support either the pulmonary, or both the pulmonary and cardiac systems.
Primary outcomes
-
survival rate
Time frame: from admission to discharge （about 10days）
survival rate after discharge
Secondary outcomes
-
time of running ECMO
Time frame: from admission to discharge（about 10days）
the total time of running ECMO
-
cost of ECMO treatment
Time frame: from admission to discharge （about 10days）
the total cost of ECMO treatment
Study contacts
Contact information is provided by the study sponsor or research team.
Sponsors and collaborators
Lead sponsor
Children's Hospital of Fudan University
Other
Registry information
Official study title
Extracorporeal Membrane Oxygenation (ECMO) Treatment of Children in Mainland China in the Past 10 Years
Important dates
- Study start
- 2021
- Primary completion
- 2026
- Study completion
- 2026
- First posted
- Jan 14, 2021
- Registry last updated
- Mar 16, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Recruiting
Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO
NCT05699005
Anemia, Cardiogenic Shock
Lille, NORD, France
View Trial Details
Recruiting
Predictors for Survival and Good Neurological Outcome in E-CPR and Non CPR Treated Patients
NCT04198792
Brain Diseases, Brain Ischemia
Gothenburg, Sweden
View Trial Details
Recruiting
Hydrogen's Feasibility and Safety as a Therapy in ECPR
NCT05574296
Cardiac Arrest, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial Details
Recruiting
Effect of Transpulmonary MP on Prognosis of Patients With Severe ARDS Treated With VV-ECMO
NCT06062212
Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation
Beijing, Beijing Municipality, China
View Trial Details